Alpha-MSH-derived peptides including KPV represent a new anti-inflammatory and immunomodulating drug class, working through NF-κB inhibition, Treg generation, and melanocortin receptor-independent pathways across multiple inflammatory conditions.
Key findingAlpha-MSH-derived peptides (KPV, ACTH fragments) constitute a new anti-inflammatory drug class operating through NF-κB inhibition, regulatory T-cell i
What the researchers found
Alpha-MSH-derived peptides (KPV, ACTH fragments) constitute a new anti-inflammatory drug class operating through NF-κB inhibition, regulatory T-cell induction, and melanocortin receptor-dependent/independent pathways — applicable to IBD, arthritis, allergic, and neuroinflammatory diseases.
Why it matters
Relevant for kpv, inflammation, immune-function.
How the study worked
review study on kpv, inflammation.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2007.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.
Annals of the rheumatic diseases, 66 Suppl 3(Suppl 3), iii52-5
Citation
Luger, Thomas A; Brzoska, Thomas. (2007). alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.. Annals of the rheumatic diseases, 66 Suppl 3(Suppl 3), iii52-5.